Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models
Authors
Keywords
NK cells, Colorectal cancer, Mouse models, Cytotoxicity, Cytotoxicity assay, HT29 cells, Flow cytometry, TGF-beta signaling cascade
Journal
PLoS One
Volume 13, Issue 1, Pages e0191358
Publisher
Public Library of Science (PLoS)
Online
2018-01-18
DOI
10.1371/journal.pone.0191358
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ex Vivo–expanded Natural Killer Cells Demonstrate Robust Proliferation In Vivo in High-risk Relapsed Multiple Myeloma Patients
- (2015) Susann Szmania et al. JOURNAL OF IMMUNOTHERAPY
- A comparative study of the effects of inhibitory cytokines on human natural killer cells and the mechanistic features of transforming growth factor-beta
- (2014) Hae mi Lee et al. CELLULAR IMMUNOLOGY
- TGF- Utilizes SMAD3 to Inhibit CD16-Mediated IFN- Production and Antibody-Dependent Cellular Cytotoxicity in Human NK Cells
- (2014) R. Trotta et al. JOURNAL OF IMMUNOLOGY
- Clinical utility of natural killer cells in cancer therapy and transplantation
- (2014) David A. Knorr et al. SEMINARS IN IMMUNOLOGY
- Cancer-Induced Alterations of NK-Mediated Target Recognition: Current and Investigational Pharmacological Strategies Aiming at Restoring NK-Mediated Anti-Tumor Activity
- (2014) Anne-Sophie Chretien et al. Frontiers in Immunology
- Plasma Exosomes as Markers of Therapeutic Response in Patients with Acute Myeloid Leukemia
- (2014) Chang-Sook Hong et al. Frontiers in Immunology
- NK cell-based immunotherapy for malignant diseases
- (2013) Min Cheng et al. Cellular & Molecular Immunology
- Activin receptor-like kinase5 inhibition suppresses mouse melanoma by ubiquitin degradation of Smad4, thereby derepressing eomesodermin in cytotoxic T lymphocytes
- (2013) Jeong-Hwan Yoon et al. EMBO Molecular Medicine
- Blocking transforming growth factor-β signaling pathway augments antitumor effect of adoptive NK-92 cell therapy
- (2013) Bo Yang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Antigen Presenting Cell-Mediated Expansion of Human Umbilical Cord Blood Yields Log-Scale Expansion of Natural Killer Cells with Anti-Myeloma Activity
- (2013) Nina Shah et al. PLoS One
- Characterization and ex vivo Expansion of Human Placenta-Derived Natural Killer Cells for Cancer Immunotherapy
- (2013) Lin Kang et al. Frontiers in Immunology
- The Critical Role of the Tumor Microenvironment in Shaping Natural Killer Cell-Mediated Anti-Tumor Immunity
- (2013) Joanna Baginska et al. Frontiers in Immunology
- Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications
- (2012) Natalia Lapteva et al. CYTOTHERAPY
- Investigation of NK cell function and their modulation in different malignancies
- (2012) Gordana Konjevic et al. IMMUNOLOGIC RESEARCH
- Complexities of TGF-β Targeted Cancer Therapy
- (2012) Erin C. Connolly et al. International Journal of Biological Sciences
- EW-7203, a novel small molecule inhibitor of transforming growth factor-β (TGF-β) type I receptor/activin receptor-like kinase-5, blocks TGF-β1-mediated epithelial-to-mesenchymal transition in mammary epithelial cells
- (2011) Chul-Yong Park et al. CANCER SCIENCE
- Use of allogeneic NK cells for cancer immunotherapy
- (2011) Melissa A Geller et al. Immunotherapy
- Clinical-Grade Generation of Active NK Cells from Cord Blood Hematopoietic Progenitor Cells for Immunotherapy Using a Closed-System Culture Process
- (2011) Jan Spanholtz et al. PLoS One
- Expansion and Activation of Natural Killer Cells for Cancer Immunotherapy
- (2009) Duck Cho et al. Korean Journal of Laboratory Medicine
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started